Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Moretti

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
The EMBO Journal|November 12, 2013
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndromeMilena Bellin, Simona Casini, Richard P Davis, et al.
Stem Cell Reports|May 24, 2016
Human Engineered Heart Tissue: Analysis of Contractile ForceIngra Mannhardt, Kaja Breckwoldt, David Letuffe-Brenière, et al.
Stem Cells (Dayton, Ohio)|December 20, 2014
Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identityTatjana Dorn, Alexander Goedel, Jason T Lam, et al.
JACC. Basic to Translational Science|January 23, 2018
Suppression of Arrhythmia by Enhancing Mitochondrial Ca<sup>2+</sup> Uptake in Catecholaminergic Ventricular Tachycardia ModelsMaria K Schweitzer, Fabiola Wilting, Simon Sedej, et al.
EMBO Molecular Medicine|December 17, 2011
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardiaChristian B Jung, Alessandra Moretti, Michael Mederos y Schnitzler, et al.
Cardiovascular Research|February 4, 2017
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytesMarcella Rocchetti, Luca Sala, Lisa Dreizehnter, et al.
Iscience|January 6, 2022
Cell cycle defects underlie childhood-onset cardiomyopathy associated with Noonan syndromeAnna B Meier, Sarala Raj Murthi, Hilansi Rawat, et al.
European Heart Journal|February 10, 2017
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytesZhifen Chen, Wenying Xian, Milena Bellin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2016
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life studyAdriano M Pellicelli, Valeria Pace Palitti, Pascal Vignally, et al.
Plos One|October 18, 2018
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathyRevital Schick, Lucy N Mekies, Yuval Shemer, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
The EMBO Journal|November 12, 2013
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndromeMilena Bellin, Simona Casini, Richard P Davis, et al.
Stem Cell Reports|May 24, 2016
Human Engineered Heart Tissue: Analysis of Contractile ForceIngra Mannhardt, Kaja Breckwoldt, David Letuffe-Brenière, et al.
Stem Cells (Dayton, Ohio)|December 20, 2014
Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identityTatjana Dorn, Alexander Goedel, Jason T Lam, et al.
JACC. Basic to Translational Science|January 23, 2018
Suppression of Arrhythmia by Enhancing Mitochondrial Ca<sup>2+</sup> Uptake in Catecholaminergic Ventricular Tachycardia ModelsMaria K Schweitzer, Fabiola Wilting, Simon Sedej, et al.
EMBO Molecular Medicine|December 17, 2011
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardiaChristian B Jung, Alessandra Moretti, Michael Mederos y Schnitzler, et al.
Cardiovascular Research|February 4, 2017
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytesMarcella Rocchetti, Luca Sala, Lisa Dreizehnter, et al.
Iscience|January 6, 2022
Cell cycle defects underlie childhood-onset cardiomyopathy associated with Noonan syndromeAnna B Meier, Sarala Raj Murthi, Hilansi Rawat, et al.
European Heart Journal|February 10, 2017
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytesZhifen Chen, Wenying Xian, Milena Bellin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2016
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life studyAdriano M Pellicelli, Valeria Pace Palitti, Pascal Vignally, et al.
Plos One|October 18, 2018
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathyRevital Schick, Lucy N Mekies, Yuval Shemer, et al.
Pageof 10